An interventional study of Survey using a questionnaire. and Survey using a questionnaire. in Screening for Colon Cancer and Survey and Questionnaire, sponsored by ADVANCED MARKER DISCOVERY S.L.. Recruiting at 2 sites in 2 countries. Open to participants aged 50 Years to 69 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-10-02.
Sponsored by ADVANCED MARKER DISCOVERY S.L. · Not applicable, Interventional, and Screening
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 53 studies in Colorectal Neoplasms with a site in Portugal — 8 open to participants now, 15 under way, 6 of them phase 3. Colorectal Neoplasms · Portugal.
Among the 53 studies in Colorectal Neoplasms with a site in Portugal, this one is the 10th largest by planned enrollment of the 41 interventional ones that give a count, is one of 3 that started in 2025, is one of 5 with no phase, reaches primary completion later than 2 of the 14 other live ones, and was the 48th registered.
6,556 studies on the registry are indexed under Colorectal Neoplasms; 1,664 are open to participants now.
Browse Colorectal Neoplasms studies →8 of the 53 studies in Colorectal Neoplasms with a site in Portugal are open now. Recruiting first, the newest first:
AbbVie · Sites in Portugal, United States, Belgium and 8 more countries
Ages 18+
Gulbenkian Institute for Molecular Medicine · Sites in Portugal
Ages 40–74
ADVANCED MARKER DISCOVERY S.L. · Sites in Portugal, Spain
Ages 50–69 · Healthy volunteers
Firalis SA · Sites in Portugal, Bulgaria, France and 3 more countries
Ages 18+
Amgen · Sites in Portugal, United States, Argentina and 32 more countries
Ages 18+
A study can be open while its sites in Portugal have not opened yet or have stopped. Only those recruiting at a site in Portugal →
Of the 1,179 Colorectal Neoplasms studies recruiting now, 762 (65%) set no upper age limit and 264 (22%) stop at 75 or younger; 48 take children under 18; 123 take healthy volunteers.
This study: 50 Years to 69 Years · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
53 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 3 · Phase 2 12 · Phase 3 27
First in 1998; this study’s year is marked. 3 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 1,000 is above the median of 76 across 4,811 interventional studies indexed under Colorectal Neoplasms.
Median enrollment 680 across the 41 interventional studies, 703 across the 8 observational. Of the 31 that completed or were terminated, 16 (52%) have results posted.
This tab as a report to print or save as PDF → With an account.
37 of 53 have an industry lead sponsor. The 10 most frequent:
ADVANCED MARKER DISCOVERY S.L. is the lead sponsor of 5 studies on the registry; 4 are open to participants now.
ADVANCED MARKER DISCOVERY S.L. has 4 studies filed under Colorectal Neoplasms — fewer than ten, so there is no comparison to draw.
3 of the studies in Colorectal Neoplasms with a site in Portugal that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06741293Gulbenkian Institute for Molecular MedicineImproving Colorectal Cancer Early Screening in Portugal: Identification of Gut Microbiome Biomarkers in Stool (GUTBIOME-PT) | 2026-11-28 |
| NCT06734156Gulbenkian Institute for Molecular MedicineCARE-CRC: Microbiome Insights and Correlations for Risk and Outcomes in Colorectal Cancer | 2026-12-02 |
| NCT06515821Firalis SAMulticentre Study for Data Collection, Development, and Evaluation of Novel CRC Screening and Diagnostic Methods | 2026-12-31 |
Add all 3 to your calendar (.ics) → With an account.
Among the 53 studies in Colorectal Neoplasms with a site in Portugal, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The goal of this low-risk interventional study is to analyze participants' assessment of colorectal cancer screening program through screening method preference and experience after FOBT analysis in screaned participant population for colorectal cancer; could include any of the following: both sexes, age 50-69 years, asympthomatic volunteers. The main aims to answer are:
Participants will answer two questionnaires and they'll be given their information and clinical data to investigator or health personnel.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Average-risk population undergoing FIT/FOBT within the colorectal cancer screening programme.
Other: Survey using a questionnaire.
Preference questionnaire for colorectal cancer screening methods
Experience questionnaire into colorectal cancer screening programme
Value of questionnaires into screening programme
The percentage of number of answers from each experience and preference questions
Time frame: 12 months
Plan to share: No
Started May 2025 (actual). Primary completion is estimated for Nov 2025, 6 months after the start.
Of 58 industry-sponsored interventional studies with no phase under Colorectal Neoplasms, half reached primary completion within 16 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 37. This study's planned 6 months is below that.
Counting every sponsor, half of 958 studies reached it within 31 months; a quarter within 14 and three quarters within 60.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
ADVANCED MARKER DISCOVERY S.L.